![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CIT-LYZ (FusionGDB2 ID:HG11113TG4069) |
Fusion Gene Summary for CIT-LYZ |
![]() |
Fusion gene information | Fusion gene name: CIT-LYZ | Fusion gene ID: hg11113tg4069 | Hgene | Tgene | Gene symbol | CIT | LYZ | Gene ID | 11113 | 4069 |
Gene name | citron rho-interacting serine/threonine kinase | lysozyme | |
Synonyms | CITK|CRIK|MCPH17|STK21 | LYZF1|LZM | |
Cytomap | ('CIT')('LYZ') 12q24.23 | 12q15 | |
Type of gene | protein-coding | protein-coding | |
Description | citron Rho-interacting kinasecitron (rho-interacting, serine/threonine kinase 21)serine/threonine kinase 21serine/threonine-protein kinase 21 | lysozyme C1,4-beta-N-acetylmuramidase Cc-type lysozymelysozyme F1 | |
Modification date | 20200320 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000261833, ENST00000392521, ENST00000537607, | ||
Fusion gene scores | * DoF score | 9 X 9 X 6=486 | 51 X 27 X 13=17901 |
# samples | 9 | 60 | |
** MAII score | log2(9/486*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(60/17901*10)=-4.89893387178018 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CIT [Title/Abstract] AND LYZ [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CIT(120260624)-LYZ(69743888), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. CIT-LYZ seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | LYZ | GO:0031640 | killing of cells of other organism | 9727055 |
Tgene | LYZ | GO:0042742 | defense response to bacterium | 21093056 |
Tgene | LYZ | GO:0050830 | defense response to Gram-positive bacterium | 21093056 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-3B-A9HO-01A | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
Top |
Fusion Gene ORF analysis for CIT-LYZ |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000261833 | ENST00000261267 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
Frame-shift | ENST00000261833 | ENST00000549690 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
Frame-shift | ENST00000392521 | ENST00000261267 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
Frame-shift | ENST00000392521 | ENST00000549690 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
In-frame | ENST00000261833 | ENST00000548839 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
In-frame | ENST00000392521 | ENST00000548839 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
intron-3CDS | ENST00000537607 | ENST00000261267 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
intron-3CDS | ENST00000537607 | ENST00000548839 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
intron-3CDS | ENST00000537607 | ENST00000549690 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000392521 | CIT | chr12 | 120260624 | - | ENST00000548839 | LYZ | chr12 | 69743888 | + | 1566 | 1167 | 26 | 1345 | 439 |
ENST00000261833 | CIT | chr12 | 120260624 | - | ENST00000548839 | LYZ | chr12 | 69743888 | + | 1563 | 1164 | 23 | 1342 | 439 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000392521 | ENST00000548839 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + | 0.001351784 | 0.9986482 |
ENST00000261833 | ENST00000548839 | CIT | chr12 | 120260624 | - | LYZ | chr12 | 69743888 | + | 0.001356238 | 0.9986438 |
Top |
Fusion Genomic Features for CIT-LYZ |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CIT | chr12 | 120260623 | - | LYZ | chr12 | 69743887 | + | 0.000602544 | 0.9993974 |
CIT | chr12 | 120260623 | - | LYZ | chr12 | 69743887 | + | 0.000602544 | 0.9993974 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for CIT-LYZ |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:120260624/chr12:69743888) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 97_360 | 370 | 2028.0 | Domain | Protein kinase |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 97_360 | 370 | 2070.0 | Domain | Protein kinase |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 103_111 | 370 | 2028.0 | Nucleotide binding | ATP |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 103_111 | 370 | 2070.0 | Nucleotide binding | ATP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 453_1297 | 370 | 2028.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 453_1297 | 370 | 2070.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 1443_1563 | 370 | 2028.0 | Domain | PH |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 1591_1881 | 370 | 2028.0 | Domain | CNH |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 361_431 | 370 | 2028.0 | Domain | AGC-kinase C-terminal |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 1443_1563 | 370 | 2070.0 | Domain | PH |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 1591_1881 | 370 | 2070.0 | Domain | CNH |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 361_431 | 370 | 2070.0 | Domain | AGC-kinase C-terminal |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 1953_1958 | 370 | 2028.0 | Motif | SH3-binding |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 1953_1958 | 370 | 2070.0 | Motif | SH3-binding |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 1362_1411 | 370 | 2028.0 | Zinc finger | Phorbol-ester/DAG-type |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 1362_1411 | 370 | 2070.0 | Zinc finger | Phorbol-ester/DAG-type |
Tgene | LYZ | chr12:120260624 | chr12:69743888 | ENST00000261267 | 0 | 4 | 19_148 | 45 | 149.0 | Domain | C-type lysozyme |
Top |
Fusion Gene Sequence for CIT-LYZ |
![]() |
>16870_16870_1_CIT-LYZ_CIT_chr12_120260624_ENST00000261833_LYZ_chr12_69743888_ENST00000548839_length(transcript)=1563nt_BP=1164nt GCGGGGCGGAACAGATCGCAGACCTGGGGGTTCGCAGAGCCGCCAGTGGGGAGATGTTGAAGTTCAAATATGGAGCGCGGAATCCTTTGG ATGCTGGTGCTGCTGAACCCATTGCCAGCCGGGCCTCCAGGCTGAATCTGTTCTTCCAGGGGAAACCACCCTTTATGACTCAACAGCAGA TGTCTCCTCTTTCCCGAGAAGGGATATTAGATGCCCTCTTTGTTCTCTTTGAAGAATGCAGTCAGCCTGCTCTGATGAAGATTAAGCACG TGAGCAACTTTGTCCGGAAGTATTCCGACACCATAGCTGAGTTACAGGAGCTCCAGCCTTCGGCAAAGGACTTCGAAGTCAGAAGTCTTG TAGGTTGTGGTCACTTTGCTGAAGTGCAGGTGGTAAGAGAGAAAGCAACCGGGGACATCTATGCTATGAAAGTGATGAAGAAGAAGGCTT TATTGGCCCAGGAGCAGGTTTCATTTTTTGAGGAAGAGCGGAACATATTATCTCGAAGCACAAGCCCGTGGATCCCCCAATTACAGTATG CCTTTCAGGACAAAAATCACCTTTATCTGGTCATGGAATATCAGCCTGGAGGGGACTTGCTGTCACTTTTGAATAGATATGAGGACCAGT TAGATGAAAACCTGATACAGTTTTACCTAGCTGAGCTGATTTTGGCTGTTCACAGCGTTCATCTGATGGGATACGTGCATCGAGACATCA AGCCTGAGAACATTCTCGTTGACCGCACAGGACACATCAAGCTGGTGGATTTTGGATCTGCCGCGAAAATGAATTCAAACAAGATGGTGA ATGCCAAACTCCCGATTGGGACCCCAGATTACATGGCTCCTGAAGTGCTGACTGTGATGAACGGGGATGGAAAAGGCACCTACGGCCTGG ACTGTGACTGGTGGTCAGTGGGCGTGATTGCCTATGAGATGATTTATGGGAGATCCCCCTTCGCAGAGGGAACCTCTGCCAGAACCTTCA ATAACATTATGAATTTCCAGCGGTTTTTGAAATTTCCAGATGACCCCAAAGTGAGCAGTGACTTTCTTGATCTGATTCAAAGCTTGTTGT GCGGCCAGAAAGAGAGACTGAAGTTTGAAGGTCTTTGCTGCCATCCTTTCTTCTCTAAAATTGACTGGAACAACATTCGTAACTGGATGT GTTTGGCCAAATGGGAGAGTGGTTACAACACACGAGCTACAAACTACAATGCTGGAGACAGAAGCACTGATTATGGGATATTTCAGATCA ATAGCCGCTACTGGTGTAATGATGGCAAAACCCCAGGAGCAGTTAATGCCTGTCATTTATCCTGCAGTGGTAAGACAAGCTAATATTTGA CCAATCTGGTTATACTTACAAGAATTGAGACTCAATACAAATGAAAAAGCCTTGAAAGGTTCATGAGGGACCTAGAAAAACTACATCTCA ACTTCCAGAAAGTCATTATTATTTTCCTCATAATTCCCTGAGTAAGAAATTAAAGAAGTGGTATCATAAAAGGTTGATGTTTTTTAATAT >16870_16870_1_CIT-LYZ_CIT_chr12_120260624_ENST00000261833_LYZ_chr12_69743888_ENST00000548839_length(amino acids)=439AA_BP=381 MGVRRAASGEMLKFKYGARNPLDAGAAEPIASRASRLNLFFQGKPPFMTQQQMSPLSREGILDALFVLFEECSQPALMKIKHVSNFVRKY SDTIAELQELQPSAKDFEVRSLVGCGHFAEVQVVREKATGDIYAMKVMKKKALLAQEQVSFFEEERNILSRSTSPWIPQLQYAFQDKNHL YLVMEYQPGGDLLSLLNRYEDQLDENLIQFYLAELILAVHSVHLMGYVHRDIKPENILVDRTGHIKLVDFGSAAKMNSNKMVNAKLPIGT PDYMAPEVLTVMNGDGKGTYGLDCDWWSVGVIAYEMIYGRSPFAEGTSARTFNNIMNFQRFLKFPDDPKVSSDFLDLIQSLLCGQKERLK -------------------------------------------------------------- >16870_16870_2_CIT-LYZ_CIT_chr12_120260624_ENST00000392521_LYZ_chr12_69743888_ENST00000548839_length(transcript)=1566nt_BP=1167nt GGCGCGGGGCGGAACAGATCGCAGACCTGGGGGTTCGCAGAGCCGCCAGTGGGGAGATGTTGAAGTTCAAATATGGAGCGCGGAATCCTT TGGATGCTGGTGCTGCTGAACCCATTGCCAGCCGGGCCTCCAGGCTGAATCTGTTCTTCCAGGGGAAACCACCCTTTATGACTCAACAGC AGATGTCTCCTCTTTCCCGAGAAGGGATATTAGATGCCCTCTTTGTTCTCTTTGAAGAATGCAGTCAGCCTGCTCTGATGAAGATTAAGC ACGTGAGCAACTTTGTCCGGAAGTATTCCGACACCATAGCTGAGTTACAGGAGCTCCAGCCTTCGGCAAAGGACTTCGAAGTCAGAAGTC TTGTAGGTTGTGGTCACTTTGCTGAAGTGCAGGTGGTAAGAGAGAAAGCAACCGGGGACATCTATGCTATGAAAGTGATGAAGAAGAAGG CTTTATTGGCCCAGGAGCAGGTTTCATTTTTTGAGGAAGAGCGGAACATATTATCTCGAAGCACAAGCCCGTGGATCCCCCAATTACAGT ATGCCTTTCAGGACAAAAATCACCTTTATCTGGTCATGGAATATCAGCCTGGAGGGGACTTGCTGTCACTTTTGAATAGATATGAGGACC AGTTAGATGAAAACCTGATACAGTTTTACCTAGCTGAGCTGATTTTGGCTGTTCACAGCGTTCATCTGATGGGATACGTGCATCGAGACA TCAAGCCTGAGAACATTCTCGTTGACCGCACAGGACACATCAAGCTGGTGGATTTTGGATCTGCCGCGAAAATGAATTCAAACAAGATGG TGAATGCCAAACTCCCGATTGGGACCCCAGATTACATGGCTCCTGAAGTGCTGACTGTGATGAACGGGGATGGAAAAGGCACCTACGGCC TGGACTGTGACTGGTGGTCAGTGGGCGTGATTGCCTATGAGATGATTTATGGGAGATCCCCCTTCGCAGAGGGAACCTCTGCCAGAACCT TCAATAACATTATGAATTTCCAGCGGTTTTTGAAATTTCCAGATGACCCCAAAGTGAGCAGTGACTTTCTTGATCTGATTCAAAGCTTGT TGTGCGGCCAGAAAGAGAGACTGAAGTTTGAAGGTCTTTGCTGCCATCCTTTCTTCTCTAAAATTGACTGGAACAACATTCGTAACTGGA TGTGTTTGGCCAAATGGGAGAGTGGTTACAACACACGAGCTACAAACTACAATGCTGGAGACAGAAGCACTGATTATGGGATATTTCAGA TCAATAGCCGCTACTGGTGTAATGATGGCAAAACCCCAGGAGCAGTTAATGCCTGTCATTTATCCTGCAGTGGTAAGACAAGCTAATATT TGACCAATCTGGTTATACTTACAAGAATTGAGACTCAATACAAATGAAAAAGCCTTGAAAGGTTCATGAGGGACCTAGAAAAACTACATC TCAACTTCCAGAAAGTCATTATTATTTTCCTCATAATTCCCTGAGTAAGAAATTAAAGAAGTGGTATCATAAAAGGTTGATGTTTTTTAA >16870_16870_2_CIT-LYZ_CIT_chr12_120260624_ENST00000392521_LYZ_chr12_69743888_ENST00000548839_length(amino acids)=439AA_BP=381 MGVRRAASGEMLKFKYGARNPLDAGAAEPIASRASRLNLFFQGKPPFMTQQQMSPLSREGILDALFVLFEECSQPALMKIKHVSNFVRKY SDTIAELQELQPSAKDFEVRSLVGCGHFAEVQVVREKATGDIYAMKVMKKKALLAQEQVSFFEEERNILSRSTSPWIPQLQYAFQDKNHL YLVMEYQPGGDLLSLLNRYEDQLDENLIQFYLAELILAVHSVHLMGYVHRDIKPENILVDRTGHIKLVDFGSAAKMNSNKMVNAKLPIGT PDYMAPEVLTVMNGDGKGTYGLDCDWWSVGVIAYEMIYGRSPFAEGTSARTFNNIMNFQRFLKFPDDPKVSSDFLDLIQSLLCGQKERLK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CIT-LYZ |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000261833 | - | 9 | 47 | 1091_1302 | 370.3333333333333 | 2028.0 | Rho/Rac |
Hgene | CIT | chr12:120260624 | chr12:69743888 | ENST00000392521 | - | 9 | 48 | 1091_1302 | 370.3333333333333 | 2070.0 | Rho/Rac |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CIT-LYZ |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CIT-LYZ |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CIT | C4310723 | MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | CIT | C3711387 | Autosomal Recessive Primary Microcephaly | 1 | ORPHANET |
Hgene | CIT | C3809431 | MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE | 1 | GENOMICS_ENGLAND |
Tgene | C0268389 | Amyloidosis, familial visceral | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |